James is a zealous advocate for clients seeking to obtain, enforce, and defend their intellectual property assets. He has extensive experience representing clients in patent, trademark, copyright, trade secret, unfair competition, false advertising, and related disputes in state and federal courts at the trial and appellate levels.
In addition to his intellectual property litigation practice, James provides strategic counsel regarding intellectual property transactions. He also advises clients regulated by the U.S. Food & Drug Administration (FDA) on matters arising under the Federal Food, Drug, and Cosmetic Act. James is involved in the firm’s Blockchain, Digital Currencies & Smart Contracts Industry Group, where he is exploring distributed ledger technology’s potential for disrupting the health care and life sciences industries.
James previously served as general counsel for an established pharmaceutical company. As the company’s chief counsel, he provided advice on legal issues related to manufacturing, distributing, marketing, and selling prescription drugs, over-the-counter medications, medical devices, and cosmetics. James’ legal practice spanned complex commercial transactions, corporate governance, intellectual property, FDA regulatory matters, and labor and employment. As general counsel, he served as first-chair, lead trial counsel in federal district court litigation involving the company. This in-house experience allows James to frame legal advice in terms of business objectives, particularly for life sciences clients.
He maintains an active research interest in the intersection between false advertising and unfair competition law and state and federal food and drug law; the interplay between state unfair and deceptive trade practice statutes and state and federal regulatory regimes; and federalism and patent law.
During law school, James served as judicial extern to the Honorable Paul M. Newby of the North Carolina Supreme Court and as a law clerk in the FDA’s Office of the Chief Counsel. Prior to law school, he worked in the health and life sciences practice of a global management consulting firm where he advised pharmaceutical manufacturers, medical device companies, and health insurance companies.